Mark Manfredi brings over two decades of international biopharmaceutical industry leadership and cancer drug discovery ...

As Big Pharma braces for a massive revenue crash when patents on blockbuster drugs expire, an unexpected player is stepping ...

Collaboration will combine Zealand Pharma's expertise in obesity and metabolic health with OTR Therapeutics' proprietary oral small-molecule platform and ...

Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on advancing medicines for obesity and metabolic health. Combining more than 25 years of peptide R&D expertise with a proprietary ...

Commentary: Health and Human Services justified its decision by citing public mistrust in vaccines based on mRNA technology, ...

Fermenta Biotech Limited (BSE: 506414) (Bloomberg: FERMENTA.IN) (Reuters: FERM.BO), India's leading manufacturer of ...

Ely Lilly’s announcement to invest $6 billion into a manufacturing plant opened up a partnership with the University of ...

In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding ...

Morning! Today, we preview a contentious generic drug dispute that may end up at the Supreme Court, discuss how the FDA’s new ...

Formation Bio is inking a deal worth more than $600 million in biobucks for ex-China rights to a next-gen immunology asset ...

Gov. Glenn Youngkin says the three big jobs announcements by pharmaceutical companies represent a “gravity pull” that can reshape the Virginia economy. Industry observers agree.

Eli Lilly announced plans to construct a $6 billion pharmaceutical manufacturing facility in Huntsville, aiming to enhance ...